Related Experiment Videos
Childhood stroke and lupus anticoagulant
J C Olson1, R J Konkol, J C Gill
1Department of Pediatrics, Medical College of Wisconsin, Milwaukee.
Pediatric Neurology
|February 1, 1994
Summary
Pediatric ischemic stroke often has an unknown cause. Evaluating children for lupus anticoagulant and anticardiolipin antibodies may reveal antiphospholipid antibody syndrome as a potential cause.
Area of Science:
- Pediatric Neurology
- Rheumatology
- Hematology
Background:
- Childhood ischemic stroke is a significant concern with many cases lacking a clear etiology.
- Antiphospholipid antibody syndrome (APS) is a known risk factor for thrombotic events.
Observation:
- Two pediatric cases presented with ischemic stroke.
- Both patients tested positive for lupus anticoagulant.
- Affected children had family histories suggestive of antiphospholipid antibody syndrome.
Findings:
- The presence of lupus anticoagulant and anticardiolipin antibodies was noted in children with unexplained ischemic stroke.
- A familial link to antiphospholipid antibody syndrome was observed.
Implications:
- Routine screening for lupus anticoagulant and anticardiolipin antibodies is recommended for children with unexplained ischemic stroke.
- Early identification of antiphospholipid antibody syndrome can guide preventative strategies and treatment in pediatric stroke patients.